Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patch for Lower Limb Amputation Pain
NCT02696720Phase 2Withdrawn
- Sponsor
- CHU Brugmann
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine in phantom limb pain (PLP) and hyperalgesia (2 arms), sponsored by CHU Brugmann. Primary endpoint: Patient-reported overall daily pain intensity. Planned start May 2016; status: withdrawn.
02
Drugs
lidocaine
03
Conditions
phantom limb pain (PLP)hyperalgesia
Beyond the preview
Go deeper on NCT02696720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02696720.